Intrinsiqq
Avalyn Pharma Inc. logo

Avalyn Pharma Inc. Insider Trading

AVLN

Compare
Last 12 months

Insiders bought $5M and sold $2.62M on the open market.

All of the selling was scheduled in advance under 10b5-1 plans.

Net open-market
+$2.38M
1 buy · 4 sales
Under a 10b5-1 plan
100%
of the value sold
Insiders who bought / sold
1 / 4
executives and directors
Last open-market buy
May 2026
May 1, 2026

Get an email when AVLN's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Nov 17 – 1810b5-1 plan
    Lyn Baranowski
    Chief Executive Officer · sold 52,500 at avg $27.84
    $1.46M
    100% of stake
  • Nov 1710b5-1 plan
    Howard Lazarus
    Chief Medical Officer · sold 13,300 at avg $27.90
    371K
    100% of stake
  • Nov 1710b5-1 plan
    Melissa Rhodes
    Chief Operating Officer · sold 13,300 at avg $27.90
    371K
    100% of stake
  • Nov 1710b5-1 plan
    Douglas R Carlson
    See Remarks · sold 14,875 at avg $27.90
    415K
    100% of stake
  • Nov 9 – 10No plan
    FMR LLC
    Large holder · sold 228,454 at avg $29.33
    $6.7M
    10% of stake
  • May 1
    Novo Holdings A/S
    Large holder · bought 555,555 at $18.00
    $10M
    17% of stake
  • May 1
    Jill Carroll
    Director · bought 277,778 at $18.00
    $5M
    15% of stake
  • May 1
    Simeon George
    Large holder · bought 555,555 at avg $18.00
    $10M
    20% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch AVLN, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Biotechnology · Pick stocks to compare with AVLN

CompareIntrinsic value
NEWBRY.XSTONewbury Pharmaceuticals AB
€0.11+0.91%40
HPHA.XETRHeidelberg Pharma AG
€2.01-2.90%10
MEDCL.XPARMedincell SA
€26.70-2.05%40
ZTEKZentek Ltd.
€0.33-0.60%40
XTXXFAdastra Holdings Ltd.
€0.08+0.00%40
XRTXXORTX Therapeutics Inc.
$0.84-5.73%10
VALNValneva SE Sponsored ADR
$5.16-3.82%0
TRIBTrinity Biotech plc Sponsored ADR
$6.24+13.66%10

Held by ETFs

AVLN is in 8 US ETFs. The largest of them, with AVLN's weight in each:

Spot a number that looks wrong?

Download this analysis as a PDF (Pro)

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing AVLN

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.